128 related articles for article (PubMed ID: 18342155)
1. [Correct use of prostate-specific antigen in office practice].
Desfemmes FR; Deligne E; Ghoundale O; Labarthe P; Berlizot P; Houlgatte A
Prog Urol; 2008 Jan; 18(1):41-5. PubMed ID: 18342155
[TBL] [Abstract][Full Text] [Related]
2. The variation of percent free prostate-specific antigen determined by two different assays.
Yang CR; Ou YC; Horng YY; Lee HS
Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171
[TBL] [Abstract][Full Text] [Related]
3. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
[TBL] [Abstract][Full Text] [Related]
4. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
Gray MA; Cooke RR; Weinstein P; Nacey JN
Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
[TBL] [Abstract][Full Text] [Related]
5. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
[TBL] [Abstract][Full Text] [Related]
6. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
[TBL] [Abstract][Full Text] [Related]
7. AFSSAPS market survey of total PSA, free PSA and complexed PSA assay kits.
Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)
Prog Urol; 2007 Apr; 17(2):176-7. PubMed ID: 17489313
[No Abstract] [Full Text] [Related]
8. [Progress in standardization of total PSA immunoassays].
Ishibashi M
Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
[TBL] [Abstract][Full Text] [Related]
9. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
[TBL] [Abstract][Full Text] [Related]
10. [The present status of convergence in PSA reference values--from the surveillance in the Tokai-Hokuriku district].
Furuta N; Takemura M; Ohta H; Akiyama M; Seishima M
Rinsho Byori; 2003 Nov; 51(11):1068-72. PubMed ID: 14679784
[TBL] [Abstract][Full Text] [Related]
11. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
13. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.
Mutlu N; Türkeri LN; Yencilek F; Demir A; Emerk K
Can J Urol; 2009 Apr; 16(2):4558-67. PubMed ID: 19364428
[TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
16. [The present status of standardization in serum total PSA measurement--a result of "Survey 2000" conducted by PSA ad hoc Committee of Japanese Urological Association].
Kano S; Ishibashi M; Itoh Y;
Rinsho Byori; 2001 Oct; 49(10):967-73. PubMed ID: 11769473
[TBL] [Abstract][Full Text] [Related]
17. [The assessment of pathological PSA values by the general practitioner--observation or intervention?].
Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V
Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670
[TBL] [Abstract][Full Text] [Related]
18. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
[TBL] [Abstract][Full Text] [Related]
19. [Prostatic specific antigen (PSA). Interpretation of results as a function of the assay method].
Benizri E; Vassault A; Nataf J; Wilmart JF; Hennequin C; Bailly M; Cukier J
Prog Urol; 1991 Jun; 1(3):413-8. PubMed ID: 1726942
[TBL] [Abstract][Full Text] [Related]
20. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
Yokomizo Y; Miyoshi Y; Nakaigawa N; Makiyama K; Ogawa T; Yao M; Kubota Y; Uemura H
Urol Int; 2009; 82(3):280-5. PubMed ID: 19440014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
